| | Authors (year) | Cell line | Treatment | Findings |
| | Xu et al. (2015) [26] | SW1353 | 100 ng/ml human TNF-α for 0, 6, 12, 24, 36, and 48 h | ↑ Cleaved caspase-3, cleaved PARP, Sam68, MMP-13, ADAMTS-5, iNOS, and IL-6
↓ IκBα, ↑ p-p65 | | Yu et al. (2018) [27] | CHON-001 (human chondrocyte cell) | IL-1β (0.1 ng/ml, 2 ng/ml, 5 ng/ml, and 10 ng/ml) | ↑ miR-126, IL-6, IL-8, and TNF-α | | Jiang et al. (2017) [28] | SW1353 | 10 ng/ml IL-1β | ↑ IL-6, IL-8, IL-10, TNF-α, MMP-2, MMP-3, MMP-9, MMP-13, BRD4, HMGB1, and nuclear p65 | | Sun et al. (2017) [29] | ATDC5 (murine articular chondrocyte) | LPS (0, 1, 5, and 10 μg/ml) for 6 hrs | ↑ miR-146a, IL-1β, IL-6, IL-8, and TNF-α
↓ CXCR4 | | Tao et al. (2015) [96] | SW1353 (human chondrosarcoma cells) | 10 ng/ml IL-1β for 0, 12, 24, 36, and 48 hrs respectively | ↑ KPNA2, MMP-13, and ADAMTS-5
↑ Nuclear p65, p-p65 | | Blaney Davidson et al. (2015) [97] | H4 (murine chondrocyte), G6 (human chondrocyte) | IL-1β (1 or 10 ng/ml) or TGF-β1 (0.1, 1, or 10 ng/ml) | ↑ NGF |
|
|
